Intravitreal administration of Coch shRNA or WAY 316606 curtailed the length of the axis in FDM animals; however, the differences in AL did not reach statistical significance at this time point ( P > 0.05, FDM vs shRNA, FDM vs WAY 316606 for 1 w, Fig. 6b ).
← all excerpts
Targeting the cochlin/SFRP1/CaMKII axis in the ocular posterior pole prevents the progression of nonpathologic myopia.
1
0.0500
0.0500